| scholarly article | Q13442814 |
| P819 | ADS bibcode | 1977PNAS...74.3028G |
| P356 | DOI | 10.1073/PNAS.74.7.3028 |
| P953 | full work available at URL | https://europepmc.org/articles/PMC431395 |
| https://europepmc.org/articles/PMC431395?pdf=render | ||
| https://pnas.org/doi/pdf/10.1073/pnas.74.7.3028 | ||
| P932 | PMC publication ID | 431395 |
| P698 | PubMed publication ID | 268650 |
| P5875 | ResearchGate publication ID | 22868156 |
| P2093 | author name string | S. Wessler | |
| R. C. Stephenson | |||
| S. N. Gitel | |||
| P2860 | cites work | AN ENZYME CASCADE IN THE BLOOD CLOTTING MECHANISM, AND ITS FUNCTION AS A BIOCHEMICAL AMPLIFIER. | Q34257237 |
| WATERFALL SEQUENCE FOR INTRINSIC BLOOD CLOTTING. | Q34257361 | ||
| INHERITED ANTITHROMBIN DEFICIENCY CAUSING THROMBOPHILIA | Q34261019 | ||
| Actions and Interactions of Antithrombin and Heparin | Q35148665 | ||
| Factor X activating enzyme from Russell's viper venom: isolation and characterization | Q42072526 | ||
| Serum levels of fibrin(ogen) degradation fragment E antigen in the diagnosis of deep vein thrombosis after abdominal and inguinal surgery | Q44181585 | ||
| Heparin action | Q44281433 | ||
| The observation of heparin on endothelium after injection | Q45239829 | ||
| Postoperative thromboses in hemophilia B. | Q45856263 | ||
| Vascular lesions in hemophilia B. | Q45856307 | ||
| Treatment of haemophilia B with purified Factor IX (PPSB). | Q45859721 | ||
| Familial thrombosis due to antithrombin 3 deficiency | Q47894264 | ||
| Thrombogenic materials in prothrombin complex concentrates | Q48502464 | ||
| Investigation of relation between use of oral contraceptives and thromboembolic disease | Q49238012 | ||
| Effects of vitamin B12, B6 and procaine on the conditioned escape response. | Q52356931 | ||
| Rabbit plasma inhibitor of the activated species of blood coagulation factor X. Purification and some properties. | Q53718244 | ||
| The inhibition of human plasmin by human antithrombin-heparin cofactor. | Q54393219 | ||
| Anticoagulant Action of Heparin | Q59048517 | ||
| Further investigations on antithrombin III in the plasmas of patients with the abnormality of antithrombin III Budapest | Q66962562 | ||
| Potentially thrombogenic materials in factor IX concentrates | Q66962565 | ||
| Inhibition of bovine factor IXa and factor Xa.beta. by antithrombin III | Q67434218 | ||
| Heparin elimination in uraemic patients on Haemodialysis | Q67799847 | ||
| Estrogen-containing oral contraceptive agents. A basis for their thrombogenicity | Q67860834 | ||
| Letter: Prothrombin-complex concentrates and thrombosis | Q69732495 | ||
| Separation of the tosyl arginine esterase activity from the factor X activating enzyme of Russell's Viper venom | Q70731257 | ||
| Heparin-accelerated inhibition of activated factor X by its natural plasma inhibitor | Q71432592 | ||
| Antithrombin III, Antifactor Xa and Heparin | Q71724311 | ||
| Bovine thrombin and activated factor X. Separation and purification | Q72017740 | ||
| Highly Purified Antithrombin III with Heparin Cofactor Activity Prepared by Disc Electrophoresis | Q72021225 | ||
| Choice of animal models for the study of disease processes in man. Introduction | Q72336047 | ||
| Quantitative aspects of antithrombin and heparin in plasma | Q73955090 | ||
| Thrombosis in the presence of vascular stasis | Q76403430 | ||
| Studies on the Antithrombin and Heparin Co-factor Activities of a Fraction Adsorbed from Plasma by Aluminum Hydroxide | Q78725627 | ||
| Biologic assay of a thrombosis-inducing activity in human serum | Q79300398 | ||
| Anticoagulant therapy in surgery | Q80645993 | ||
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heparin | Q190016 |
| P304 | page(s) | 3028-3032 | |
| P577 | publication date | 1977-07-01 | |
| P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
| P1476 | title | In vitro and in vivo correlation of clotting protease activity: effect of heparin | |
| In vitro and in vivo correlation of clotting protease activity: Effect of heparin | |||
| P478 | volume | 74 |
| Q36618545 | 2 Mechanisms of action of low molecular weight heparins and heparinoids |
| Q40342950 | Active site-blocked factor IXa prevents intravascular thrombus formation in the coronary vasculature without inhibiting extravascular coagulation in a canine thrombosis model |
| Q47447917 | Elevated Plasma Factor IXa Activity in Premenopausal Women on Hormonal Contraception. |
| Q34104373 | Factor IX and thrombosis |
| Q36138249 | Factor IX concentrates: the new products and their properties |
| Q68483210 | Haemostatic disturbances in patients bitten by Russell's viper (Vipera russelli siamensis) in Burma |
| Q41447983 | In vivo evidence of intravascular binding sites for coagulation factor IX. |
| Q36295906 | Low molecular weight heparin inhibits plasma thrombin generation via direct targeting of factor IXa: contribution of the serpin-independent mechanism |
| Q39797855 | Low-dose heparin: Is the risk worth the benefit? |
| Q73378444 | Manufacturing of a prothrombin complex concentrate aiming at low thrombogenicity |
| Q34268523 | Mechanism of the anticoagulant action of heparin |
| Q34086042 | Occlusive vascular diseases in oral contraceptive users. Epidemiology, pathology and mechanisms |
| Q36987361 | Translation and Clinical Development of Antithrombotic Aptamers |
Search more.